Eton Pharmaceuticals Stock Alpha and Beta Analysis

ETON Stock  USD 15.58  0.98  6.71%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Eton Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Eton Pharmaceuticals over a specified time horizon. Remember, high Eton Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Eton Pharmaceuticals' market risk premium analysis include:
Beta
0.67
Alpha
0.44
Risk
4.8
Sharpe Ratio
0.0935
Expected Return
0.45
Please note that although Eton Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Eton Pharmaceuticals did 0.44  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Eton Pharmaceuticals stock's relative risk over its benchmark. Eton Pharmaceuticals has a beta of 0.67  . As returns on the market increase, Eton Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Eton Pharmaceuticals is expected to be smaller as well. At this time, Eton Pharmaceuticals' Book Value Per Share is very stable compared to the past year. As of the 15th of March 2025, Enterprise Value is likely to grow to about 71.5 M, while Tangible Book Value Per Share is likely to drop 0.46.

Enterprise Value

71.47 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Eton Pharmaceuticals Backtesting, Eton Pharmaceuticals Valuation, Eton Pharmaceuticals Correlation, Eton Pharmaceuticals Hype Analysis, Eton Pharmaceuticals Volatility, Eton Pharmaceuticals History and analyze Eton Pharmaceuticals Performance.
To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.

Eton Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Eton Pharmaceuticals market risk premium is the additional return an investor will receive from holding Eton Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Eton Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Eton Pharmaceuticals' performance over market.
α0.44   β0.67

Eton Pharmaceuticals expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Eton Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Eton Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Eton Pharmaceuticals Market Price Analysis

Market price analysis indicators help investors to evaluate how Eton Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eton Pharmaceuticals shares will generate the highest return on investment. By understating and applying Eton Pharmaceuticals stock market price indicators, traders can identify Eton Pharmaceuticals position entry and exit signals to maximize returns.

Eton Pharmaceuticals Return and Market Media

The median price of Eton Pharmaceuticals for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 14.41 with a coefficient of variation of 12.92. The daily time series for the period is distributed with a sample standard deviation of 1.88, arithmetic mean of 14.58, and mean deviation of 1.57. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Disposition of 20000 shares by David Krempa of Eton Pharmaceuticals at 5.76 subject to Rule 16b-3
12/13/2024
2
Eton Pharmaceuticals stock soars to all-time high of 14.05 - Investing.com
01/02/2025
3
Disposition of 27400 shares by Riedel Norbert G of Eton Pharmaceuticals at 3.58 subject to Rule 16b-3
01/06/2025
4
Disposition of 159300 shares by Opaleye Management Inc. of Eton Pharmaceuticals at 6.3011 subject to Rule 16b-3
01/10/2025
5
Insider Trading
01/17/2025
6
Acquisition by David Krempa of 42088 shares of Eton Pharmaceuticals subject to Rule 16b-3
01/21/2025
7
Eton Pharmaceuticals, Inc. On The Verge Of Breaking Even - Simply Wall St
01/22/2025
8
HC Wainwright Issues Positive Forecast for Eton Pharmaceuticals Stock Price
01/24/2025
9
Heres What Could Help Eton Pharmaceuticals Maintain Its Recent Price Strength
01/27/2025
10
Eton Solutions, the leading WealthTech platform powered by AI, partners with Trigen Wealth, a newly launched full service Multi-Family Office in India
01/28/2025
11
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
02/07/2025
12
EcoR1 Capital, LLC Increases Stake in Eton Pharmaceuticals Inc
02/14/2025
13
Eton Pharmaceuticals Announces Commercial Launch of Galzin Capsules
03/03/2025
14
Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results ...
03/04/2025
15
Rocket Companies, Novo Nordisk And Other Big Stocks Moving Lower In Mondays Pre-Market Session
03/10/2025

About Eton Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Eton or other stocks. Alpha measures the amount that position in Eton Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2024 2025 (projected)
Dividend Yield0.0240.0214
Price To Sales Ratio4.083.88

Eton Pharmaceuticals Upcoming Company Events

As portrayed in its financial statements, the presentation of Eton Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Eton Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Eton Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Eton Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Eton Pharmaceuticals' management manipulating its earnings.
21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Eton Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Eton Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eton Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eton Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eton Pharmaceuticals Stock:
Eton Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Eton Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Eton Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...